Home > Insider Trading > Filing (0001123292-21-001196)

Filing Details

Accession Number:: 0001123292-21-001196
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-06 19:19:16
Reporting Period:: 2021-08-06

Accepted Time:: 2021-08-06 19:19:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1773751	Hims & Hers Health Inc.	HIMS	Services-Offices & Clinics Of Doctors Of Medicine (8011)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1841848	Jack Abraham	C/O Atomic Labs, Llc Building C, 1 Letterman Drive, Ste 3500 San Francisco CA 94129		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2021-08-06	4,012	$0.00	721,539	No	4	X	Direct
Class A Common Stock	Acquisiton	2021-08-06	1,559	$0.00	280,430	No	4	X	Indirect	See Footnote
Class A Common Stock	Acquisiton	2021-08-06	7,280	$0.00	1,309,256	No	4	X	Indirect	See Footnote
Class A Common Stock	Acquisiton	2021-08-06	5,442	$0.00	978,653	No	4	X	Indirect	See Footnote
Class A Common Stock	Acquisiton	2021-08-06	45,626	$0.00	8,204,647	No	4	X	Indirect	See Footnote
Class A Common Stock	Acquisiton	2021-08-06	46,238	$0.00	8,314,803	No	4	X	Indirect	See Footnote
Class A Common Stock	Acquisiton	2021-08-06	24,449	$0.00	4,396,480	No	4	X	Indirect	See Footnote
Class A Common Stock	Disposition	2021-08-06	2,941	$0.00	718,598	No	4	S	Direct
Class A Common Stock	Disposition	2021-08-06	1,143	$0.00	279,287	No	4	S	Indirect	See Footnote
Class A Common Stock	Disposition	2021-08-06	5,337	$0.00	1,303,919	No	4	S	Indirect	See Footnote
Class A Common Stock	Disposition	2021-08-06	3,989	$0.00	974,664	No	4	S	Indirect	See Footnote
Class A Common Stock	Disposition	2021-08-06	33,444	$0.00	8,171,203	No	4	S	Indirect	See Footnote
Class A Common Stock	Disposition	2021-08-06	33,893	$0.00	8,280,910	No	4	S	Indirect	See Footnote
Class A Common Stock	Disposition	2021-08-06	17,922	$0.00	4,378,558	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Direct
No	4	X	Indirect	See Footnote
No	4	X	Indirect	See Footnote
No	4	X	Indirect	See Footnote
No	4	X	Indirect	See Footnote
No	4	X	Indirect	See Footnote
No	4	X	Indirect	See Footnote
No	4	S	Direct
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Warrants (right to buy)	Disposition	2021-08-06	4,012	$0.00	4,012	$0.00
Class A Common Stock	Warrants (right to buy)	Disposition	2021-08-06	1,559	$0.00	1,559	$0.00
Class A Common Stock	Warrants (right to buy)	Disposition	2021-08-06	7,280	$0.00	7,280	$0.00
Class A Common Stock	Warrants (right to buy)	Disposition	2021-08-06	5,442	$0.00	5,422	$0.00
Class A Common Stock	Warrants (right to buy)	Disposition	2021-08-06	45,626	$0.00	45,626	$0.00
Class A Common Stock	Warrants (right to buy)	Disposition	2021-08-06	46,238	$0.00	46,238	$0.00
Class A Common Stock	Warrants (right to buy)	Disposition	2021-08-06	24,449	$0.00	24,449	$0.00

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2021-02-19	2026-01-20	No	4	X	Direct
2021-02-19	2026-01-20	No	4	X	Indirect
2021-02-19	2026-01-20	No	4	X	Indirect
2021-02-19	2026-01-20	No	4	X	Indirect
2021-02-19	2026-01-20	No	4	X	Indirect
2021-02-19	2026-01-20	No	4	X	Indirect
2021-02-19	2026-01-20	No	4	X	Indirect

Footnotes

Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised.
These securities are owned directly by the Reporting Person. The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities.
Securities are owned by Atomic Incentives, LLC ("Incentives"). Atomic Labs, LLC ("Labs") is the sole member of Incentives. The Reporting Person is the sole manager of Labs and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Incentives.
Securities are owned by Atomic Labs I, L.P. ("Labs I"). Atomic Labs GP I, LLC ("Labs GP I") is the general partner of Labs I. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owner by Labs I.
Securities are owned by Atomic Labs I-B, L.P. ("Labs I-B"). Labs GP I is the general partner of Labs I-B. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs I-B.
Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41.
Securities are owned by Atomic Labs II, L.P. ("Labs II"). Atomic Labs GP II, LLC ("Labs GP II") is the general partner of Labs II. The Reporting Person is a managing member of Labs GP II and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs II.
Securities are held by The Jack Abraham 2020 Irrevocable Trust A, which is a trust the holdings of which may be attributable to the Reporting Person.
Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above.